# Hyperbaric Novabupi® in Spinal Anesthesia in Lower Limbs Vascular Surgery

> **NCT03883763** · PHASE3 · UNKNOWN · sponsor: **Cristália Produtos Químicos Farmacêuticos Ltda.** · enrollment: 120 (estimated)

## Conditions studied

- Spinal Anesthesia
- Vascular Surgery

## Interventions

- **DRUG:** bupivacaine S75:R25 plus 8% glucose
- **DRUG:** bupivacaine S50:R50 plus 8% glucose

## Key facts

- **NCT ID:** NCT03883763
- **Lead sponsor:** Cristália Produtos Químicos Farmacêuticos Ltda.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-01
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03883763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03883763, "Hyperbaric Novabupi® in Spinal Anesthesia in Lower Limbs Vascular Surgery". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03883763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*